Chronic News and Research

RSS

New integrated framework advances precision surgery for liver cancer

Hepatocellular carcinoma is the sixth most common malignancy and the third leading cause of cancer-related death globally.

9 Sep 2026

New AI model forecasts glucose changes in type 1 diabetes patients

Diabetes is one of the most common chronic diseases, affecting around 66 million adults in Europe - a figure projected to rise to more than 72 million by 2050.

9 Sep 2026

Johns Hopkins researchers identify human resistin as a key driver of inflammation

Researchers at Johns Hopkins Medicine have uncovered a critical biological mechanism that helps explain how inflammation is triggered and sustained in a wide range of diseases-highlighting a promising avenue for future therapeutic development.

9 Sep 2026

Astrocyte changes may explain how stress affects mental health

A new study led by UCLA Health researchers has identified a specific type of brain cell and a tiny structure on its surface that changes when the body is under stress, which may help explain why stress can lead to anxiety and depression.

8 Sep 2026

Laptop heat exposure causes rare skin rash and discoloration

Balancing an electronic device on bare skin risks disfiguration, doctors warn in the online journal BMJ Case Reports, after treating a child with skin discoloration and a 'fishnet' rash -hallmarks of erythema ab igne-caused by repeated exposure to the low grade heat from a laptop.

8 Sep 2026

Menopause documented far less often in electronic health records

Menopause is frequently missing from women's electronic health records, according to a University of Colorado Anschutz study of nearly 396,000 women participating in the National Institutes of Health's All of Us Research Program.

8 Sep 2026

Integrated mental health care could transform Canada's primary care

As Prime Minister Mark Carney prepares to host the inaugural Canada Investment Summit in Toronto this September, a new review co-led by researchers at UBC argues that the country is leaving one of its largest economic and health-care system opportunities untouched: the integration of psychological care into primary care.

8 Sep 2026

Rice, seafood and water may help explain striking differences in metal exposure across US communities

Researchers compared urinary trace-metal profiles across 666 adults from six ethnic groups in three US cohorts, with up to 19 elements measured and paired serum measurements available for the Asian Indian MASALA cohort. Distinct metal patterns emerged across populations, with the findings suggesting that diet, drinking-water sources, regional hydrogeology, urban-rural conditions, smoking, and physiological handling may all contribute to differences in exposure profiles.

8 Sep 2026

Researchers use an experimental drug to reverse the effects of systemic sclerosis

Investigators at Cedars-Sinai Health Sciences University used an experimental drug to reverse the effects of systemic sclerosis, a serious autoimmune disease. The study, conducted in a laboratory, was published in JCI Insight.

8 Sep 2026

New approach repairs airway barrier defects in cystic fibrosis

A UNIGE team has succeeded in restoring the defective respiratory protective barrier in people with this rare genetic disease.

8 Sep 2026

Retinal immune cell gateway may unlock targeted uveitis treatments

As part of an effort to understand the molecules and mechanisms that regulate transendothelial migration in different vascular beds of the body, researchers focused on the blood vessels of the retina, part of the blood-brain barrier.

8 Sep 2026

Teens can now order lunch from almost anywhere. Schools are facing a new dilemma

A national survey of 1,027 US adolescents aged 13 to 17 found that nearly one in four reported using mobile food delivery services during school hours, while almost half used them after school. Fast food and sugar-sweetened beverages were among the most commonly ordered items through delivery apps overall, while students also raised concerns about cost, inequality, safety, and disruption at school.

8 Sep 2026

High-dose flu vaccine protects older adults with lung disease

The risk of being hospitalized for flu or pneumonia can be reduced with a high-dose flu vaccine for older people with chronic lung disease, according to the combined results of two large clinical trials presented at the European Respiratory Society (ERS) Congress in Barcelona, Spain.

8 Sep 2026

New biologic therapy significantly reduces COPD flare-ups in trials

Two international clinical trials led in part by researchers at the University of Pittsburgh School of Medicine found that the investigational biologic therapy tozorakimab significantly reduced chronic obstructive pulmonary disease (COPD) flare-ups among patients already receiving standard treatment for the disease compared to patients only receiving standard treatment.

8 Sep 2026

Working shifts may change more than your sleep schedule

A cross-sectional analysis of 1,814 Japanese workers found that shift work was associated with lower raw seafood intake and shorter sleep patterns in both sexes, while female shift workers also consumed less milk and dairy products. Total energy intake was similar between work groups, but male shift workers were more likely to consider preference and convenience when choosing foods, highlighting potentially important differences in dietary quality and lifestyle rather than calorie intake.

8 Sep 2026

Severe asthma inflammation linked to structural changes in the brain

People living with a severe form of asthma show subtle differences in the structure of their brains compared with people whose asthma is well controlled, according to new research presented at the European Respiratory Society (ERS) Congress in Barcelona, Spain.

8 Sep 2026

Could scorpion venom inspire new treatments for liver disease?

Scorpion venom peptides show promising anti-inflammatory, antiviral, analgesic, and immunomodulatory effects, with experimental evidence suggesting that some candidates could target pathways involved in chronic liver disease and viral hepatitis. The review highlights Kv1.3-blocking peptides and antiviral compounds as potential therapeutic leads, while emphasizing that limited hepatic efficacy data, poor pharmacokinetics, immunogenicity, and manufacturing challenges must be overcome before clinical translation.

8 Sep 2026

Could one amino acid help explain why men tend to live shorter lives?

A UK Biobank cohort and Mendelian randomization study involving 272,475 participants linked higher circulating tyrosine with greater all-cause mortality and genetically predicted higher tyrosine with shorter lifespan. After accounting for phenylalanine, the relationship with shorter lifespan was clearest in men, while findings in women were less consistent, suggesting a potential sex-specific role for tyrosine in longevity.

7 Sep 2026

GLP-1 drugs looked promising for depression. The evidence tells a more complicated story

A systematic review of 43 studies found highly heterogeneous results for GLP-1 receptor agonists across animal models and human research assessing depression-, anxiety-, and stress-related outcomes. No study directly tested these drugs as a treatment for PTSD, and the available evidence does not currently support their use for depression or PTSD, although people with metabolic dysfunction may warrant further investigation.

7 Sep 2026

Psilocybin microdosing sounds promising, but the strongest studies tell a different story

A systematic review of 11 studies involving 3,262 adults found that psilocybin mushroom and truffle microdosing was associated with reported improvements across areas including mental health, well-being, cognition, creativity, and social functioning. However, the evidence was methodologically weak and highly heterogeneous, the two placebo-controlled trials found no significant improvements, and inadequate adverse-event reporting means efficacy and safety remain uncertain.

7 Sep 2026